Kirsti L. Walker

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells

C. Crane, M. Bouchlaka, C. Capitini, 2018, Front. Immunol..

Efficacy of JAK1/2 and BCL2 inhibition on human T cell acute lymphoblastic leukemia in vitro and in vivo

L. Rui, M. Bouchlaka, C. Capitini, 2019, bioRxiv.

Efficacy of JAK1/2 and BCL2 inhibition on human T cell acute lymphoblastic leukemia in vitro and in vivo

L. Rui, M. Bouchlaka, C. Capitini, 2019, bioRxiv.

Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo‐inactivation and ILC2‐mediated tissue repair

J. Tolar, S. Sebti, J. Pidala, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation.

M. Bouchlaka, C. Capitini, P. Sondel, 2020, Cytotherapy.

Detection and viability of murine NK cells in vivo in a lymphoma model using fluorine‐19 MRI

S. Fain, Lawrence M Lechuga, C. Capitini, 2021, NMR in biomedicine.

90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin’s Lymphoma

J. Engle, R. Hernandez, J. Weichert, 2019, Communications Biology.

CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration

L. Rui, C. Capitini, Monica M. Cho, 2021, Leukemia & lymphoma.